Volume 18, Number 6—June 2012
CME ACTIVITY - Synopsis
Iatrogenic Creutzfeldt-Jakob Disease, Final Assessment
|Country||Source of infection and no. cases
|Dura mater grafts||Surgical instruments||EEG needles||Corneal transplants†||Growth hormone‡||Gonadotropin||Packed red blood cells§|
†Additional possible single cases after corneal transplant or keratoplasty (not included in table) in Japan, United Kingdom, and United States.
‡Human growth hormone given in Brazil and New Zealand was prepared in the United States; that given in Qatar was prepared in France. Additional possible single cases with human growth hormone as source (not included in table) occurred in Sweden, Australia, and New Zealand.
§An additional asymptomatic but infected red-cell recipient died of an unrelated illness; another asymptomatic infected hemophilia patient who had been exposed to potentially contaminated factor VIII also died of an unrelated illness (neither is included in the table).
- Page created: May 17, 2012
- Page last updated: May 17, 2012
- Page last reviewed: May 17, 2012
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)